Horan Securities Inc. Makes New Investment in Stryker Corporation $SYK

Horan Securities Inc. purchased a new stake in Stryker Corporation (NYSE:SYK) in the 2nd quarter, Holdings Channel.com reports. The fund purchased 509 shares of the medical technology company’s stock, valued at approximately $201,000.

Several other hedge funds have also made changes to their positions in SYK. Brighton Jones LLC boosted its stake in Stryker by 15.4% in the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock worth $1,643,000 after buying an additional 609 shares during the last quarter. Penserra Capital Management LLC lifted its holdings in shares of Stryker by 125.8% during the 1st quarter. Penserra Capital Management LLC now owns 2,032 shares of the medical technology company’s stock worth $756,000 after acquiring an additional 1,132 shares during the period. Envestnet Asset Management Inc. boosted its position in shares of Stryker by 1.1% in the first quarter. Envestnet Asset Management Inc. now owns 632,180 shares of the medical technology company’s stock worth $235,329,000 after acquiring an additional 7,046 shares during the last quarter. TD Private Client Wealth LLC grew its holdings in Stryker by 5.3% in the first quarter. TD Private Client Wealth LLC now owns 5,429 shares of the medical technology company’s stock valued at $2,021,000 after purchasing an additional 272 shares during the period. Finally, U.S. Capital Wealth Advisors LLC increased its position in Stryker by 1.7% during the first quarter. U.S. Capital Wealth Advisors LLC now owns 3,633 shares of the medical technology company’s stock worth $1,352,000 after purchasing an additional 61 shares during the last quarter. Institutional investors and hedge funds own 77.09% of the company’s stock.

Stryker Price Performance

Shares of NYSE SYK opened at $357.76 on Thursday. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.78 and a quick ratio of 1.06. Stryker Corporation has a 1-year low of $329.16 and a 1-year high of $406.19. The company has a market capitalization of $136.82 billion, a price-to-earnings ratio of 47.39, a PEG ratio of 2.66 and a beta of 0.94. The business has a 50-day moving average of $376.08 and a 200-day moving average of $381.07.

Stryker (NYSE:SYK) last released its quarterly earnings results on Thursday, October 30th. The medical technology company reported $3.19 EPS for the quarter, topping the consensus estimate of $3.13 by $0.06. The firm had revenue of $6.06 billion for the quarter, compared to analyst estimates of $6.04 billion. Stryker had a return on equity of 23.94% and a net margin of 12.25%.Stryker’s revenue for the quarter was up 10.2% on a year-over-year basis. During the same period in the previous year, the company posted $2.87 EPS. Stryker has set its FY 2025 guidance at 13.500-13.600 EPS. On average, equities analysts anticipate that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the stock. Evercore ISI decreased their price target on shares of Stryker from $410.00 to $405.00 and set an “outperform” rating on the stock in a report on Friday, October 31st. Sanford C. Bernstein reiterated an “outperform” rating on shares of Stryker in a report on Monday. Rothschild & Co Redburn assumed coverage on Stryker in a research note on Thursday, September 18th. They set a “neutral” rating and a $420.00 price target for the company. UBS Group set a $408.00 price objective on Stryker in a research note on Monday, October 13th. Finally, Barclays boosted their target price on Stryker from $443.00 to $453.00 and gave the stock an “overweight” rating in a report on Wednesday, October 22nd. Fourteen investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $433.37.

Insiders Place Their Bets

In related news, insider Viju Menon sold 500 shares of Stryker stock in a transaction on Monday, August 25th. The shares were sold at an average price of $390.61, for a total transaction of $195,305.00. Following the sale, the insider owned 12,511 shares of the company’s stock, valued at $4,886,921.71. The trade was a 3.84% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 5.90% of the company’s stock.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.